Thus, we can estimate that the use of the GT Plus assay as a reflex test after the GT II assay would have decreased the overall ratio of HCV-1 samples in need of subtyping by the reference method from 5.7% down to 1.1%, which translates into a successful resolution of 98.9% of all HCV-1 samples when the two Abbott genotyping assays are combined
A prospective multisite trial is being organized to test whether GLP-1 therapy can lower breast cancer incidence in high-risk women
By submitting this form, you consent to be contacted via email and/or SMS text message regarding promotions, products, and important updates, and you understand and acknowledge that Currax Pharmaceuticals LLC may use your information in accordance with its Privacy Policy
Oncotarget 6(38):4065540666 Ye J, Huang Q, Xu J et al (2018) Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth
Consult your doctor if you have: Pancreatitis or a history of inflammation in the pancreas
GLP-1 receptor agonists like Semaglutide were originally developed to help regulate blood sugar in people with type 2 diabetes, but the research that followed told a much bigger story